Article

Seven MFN and IRP mistakes that can put millions at risk

  • Rafael de Alencar headshot

    Rafael de Alencar

Avoid costly pricing missteps by understanding the common MFN and IRP risks that can impact global pricing strategy, market access, and long-term revenue.
As Most Favored Nation and international reference pricing models evolve, manufacturers face growing pressure to protect global price integrity. A single visible price, discount, or access decision can influence payer expectations across markets, affecting launch sequencing, negotiations, and long-term revenue.

This article outlines seven common MFN and IRP mistakes — and the practical steps manufacturers can take to quantify exposure early, strengthen governance, defend value, and reduce cross-market spillover risk.

Click below to read the full article and learn more:

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.
abstract

Related resources

Article

EU JCA and US MFN collision: The next global pricing and market access risk frontier

Article

The future of managed care: How AI can transform pharmacy operations by 2030
A light-skinned person with long brown hair holding a tablet and stylus smiles at a colleague during a meeting in a conference room.

Article

IRP: The global impact of a single price decision